Clinical Studies Ongoing Process for Identifying New Breakthroughs in … – MarketWatch

CORAL SPRINGS, Florida, October 9, 2014 /PRNewswire via COMTEX/ — CORAL SPRINGS, Florida, October 9, 2014 /PRNewswire/ —

Recent studies and clinical trials reveal data to back effectiveness of Cannabidiol “CBD” Hemp oil as a medical treatment, marijuana industry forecasted to exceed $8 billion in next four years: Earth Science Tech, Inc. ETST, +0.97% GW Pharmaceuticals plc GWPH, +1.44% CannaVest Corp. CANV, -2.55% INSYS Therapeutics, Inc. INSY, +1.08% and Vape Holdings, Inc. VAPE, +0.68%

Earth Science Tech, Inc. (otcqb:ETST), a unique biotechnology company focused on neutraceuticals, bioceuticals and dietary supplements, announced today that ETST has received an initial report from the Sponsored Research Agreement with the University of Central Oklahoma a public institution of higher education, showing the effects of its Hemp Oil Enriched with CBD-Cannabidiol (provided by Earth Science Tech, Inc.) on animal breast cancer cells and on normal cells.

ETST confirmed these preliminary results on its Hemp Oil Enriched with CBD-Cannabidiol and the update regarding the Grant and Study with the University of Central Oklahoma lead investigator Dr. Wei R. Chen have been received.

To read the full press release, please click here: http://www.financialnewsmedia.com/profiles/etst.html

The results of this preliminary study indicate that with appropriate dose, in this case with its proprietary Hemp Oil Enriched with CBD-Cannabidiol dose, Hemp Oil Enriched with CBD-Cannabidiol can inhibit the proliferation of cancer cells more than that of normal cells. If Hemp Oil Enriched with CBD-Cannabidiol has the same effect in vivo, it may help with cancer patients. However, further experiments are needed to investigate the effects of Hemp Oil Enriched with CBD-Cannabidiol on different cells, particularly on immune cells. CEO of ETST, Harvey Katz, PhD declared: “Our unique position working within …read more